Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients

NCT02327702 is registered in ClinicalTrials.gov with Asian-Pacific Alliance of Liver Disease, Beijing as lead sponsor.

NCT NCT02327702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02327702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients
Lead sponsor
Asian-Pacific Alliance of Liver Disease, Beijing
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2015
Completion date
July 31, 2017
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic, pregnancy